More than 6,500 Connecticut residents battle the effects of multiplesclerosis, a potentially debilitating disease that affects the central
nervous system. In a show of suppor...
More than 6,500 Connecticut residents battle the effects of multiplesclerosis, a potentially debilitating disease that affects the central
nervous system. In a show of suppor...
Climb to the Top Boston is a unique event that raises funds to help
more than 21,000 people in ME, MA, NH, RI and VT affected by multiplesclerosis, a disease of the central n...
God Street Wine, Strangefolk, Assembly of Dust
The Capitol Theatre
01/15/2016 08:00 PM EST
$35 // $50 (ADVANCE) $40 // $55 (DAY OF SHOW)
buy tickets
[https://www.ticke...
Objective
Damage to the cerebral tissue structural connectivity associated with
amyotrophic lateral sclerosis (ALS), which extends beyond the motor
pathways, can be visualise...
In the first mouse model of the progressive form of multiplesclerosis, nanoparticles that created immune tolerance to myelin
prevented the development of progressive MS.
Teva Pharmaceutical and Active Biotech announced they were ending the
higher-dose portions of two multiple-sclerosis studies involving the
drug Laquinimod, after patients suff...
Well now, 2016 has started off with a bang for your Life With multiplesclerosis blogger! I awoke New Year’s Day to an inbox full of
greetings and one particular email from ...
[http://2.bp.blogspot.com/-S2UkDtwtzxg/VoGsDxIQH9I/AAAAAAACfG8/8q2kngfXOy4/s1600/pot.jpg]Columbia
Care, one of NYC's first medicinal marijuana dispensaries, opens today
at 21...
In their recently proposed rule
[https://s3.amazonaws.com/public-inspection.federalregister.gov/2015-29884.pdf],
the Centers for Medicare and Medicaid Services (CMS) created a...
I know, I know… where have I been? Well, frankly enjoying life and
my four kids as I help the last ones ‘out of the nest.’ Four
kids… and after feeling like it would n...
2015 was a good year for innovation in medicine in both the EU and the
US, according to data published on Monday (4 January).
The European Medicines Agency (EMA) recomm...